| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jan 7, 2013
Perrigo Company (Nasdaq: PRGO; TASE) today announced that its infant formula division has gained FDA clearance to manufacture three new infant formula...
-
Jan 2, 2013
Perrigo Company (Nasdaq: PRGO; TASE) today announced that Perrigo Chairman, President and CEO Joseph C. Papa will present at the J.P. Morgan 31st...
-
Dec 28, 2012-- Solidifies Perrigo's leadership position in topical foam-based generic prescription pharmaceuticals
Perrigo Company (Nasdaq: PRGO; TASE) today announced that it has signed a definitive merger agreement and has completed the acquisition of Cobrek...
-
Dec 4, 2012
The Perrigo Company (Nasdaq: PRGO;TASE) today announced the appointment of Douglas Boothe as Executive Vice President and General Manager, Perrigo...
-
Nov 28, 2012
Perrigo Company (Nasdaq: PRGO; TASE) today announced that it has agreed to settle its Hatch-Waxman litigation relating to Ofirmev® (acetaminophen)...
-
Nov 27, 2012
Perrigo Company (Nasdaq: PRGO;TASE) today announced that its partner, Cobrek Pharmaceuticals, Inc., received final approval from the U.S. Food and...
-
Nov 13, 2012
Perrigo Company (Nasdaq: PRGO;TASE) today announced that Perrigo Chairman, President and CEO Joseph C. Papa will present at the Credit Suisse...
-
Nov 13, 2012
Perrigo Company (Nasdaq: PRGO; TASE) today announced that it has agreed to settle its Hatch-Waxman litigation relating to Acetadote® (acetylcysteine)...
-
Nov 7, 2012- Fiscal first quarter adjusted net income increased 16% to a record $119 million, or $1.27 per diluted share, inclusive of an $0.08 tax benefit.
Perrigo Company (Nasdaq: PRGO; TASE: PRGO) today announced results for its first quarter ended September 29, 2012. (Logo:...
-
Nov 6, 2012
The Perrigo Company (Nasdaq: PRGO;TASE) today announced that its Board of Directors has appointed Jacqualyn A. Fouse, Ph.D. as a new director of the...